Steps ahead in the treatment of advanced colorectal cancer: past, current and possible future scenarios

被引：5
作者：
Aprile, Giuseppe [1 ]
Rihawi, Karim [1 ]
Scartozzi, Mario [2 ]
Bordonaro, Roberto [3 ]
机构：
[1] Univ & Gen Hosp, Dept Med Oncol, Udine, Italy
[2] Univ Hosp, Dept Oncol, Cagliari, Italy
[3] ARNAS Garibaldi, Dept Oncol, Catania, Italy
来源：
FUTURE ONCOLOGY | 2015年 / 11卷 / 19期
关键词：
antiangiogenics; clinical research; colorectal cancer; EGFR inhibitors; translational research; CETUXIMAB PLUS IRINOTECAN; PHASE-III TRIAL; 1ST-LINE TREATMENT; INFUSIONAL FLUOROURACIL; RANDOMIZED-TRIAL; OPEN-LABEL; BEVACIZUMAB; LEUCOVORIN; OXALIPLATIN; FOLFIRI;
D O I：
10.2217/fon.15.213
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2625 / 2628
页数：4
相关论文
共 21 条
[1]   Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer [J].
Cunningham, D ;
Humblet, Y ;
Siena, S ;
Khayat, D ;
Bleiberg, H ;
Santoro, A ;
Bets, D ;
Mueser, M ;
Harstrick, A ;
Verslype, C ;
Chau, I ;
Van Cutsem, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (04) :337-345
[2]   Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial [J].
Cunningham, David ;
Lang, Istvan ;
Marcuello, Eugenio ;
Lorusso, Vito ;
Ocvirk, Janja ;
Shin, Dong Bok ;
Jonker, Derek ;
Osborne, Stuart ;
Andre, Niko ;
Waterkamp, Daniel ;
Saunders, Mark P. .
LANCET ONCOLOGY, 2013, 14 (11) :1077-1085
[3]   Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study [J].
Douillard, Jean-Yves ;
Siena, Salvatore ;
Cassidy, James ;
Tabernero, Josep ;
Burkes, Ronald ;
Barugel, Mario ;
Humblet, Yves ;
Bodoky, Gyoergy ;
Cunningham, David ;
Jassem, Jacek ;
Rivera, Fernando ;
Kocakova, Ilona ;
Ruff, Paul ;
Blasinska-Morawiec, Maria ;
Smakal, Martin ;
Canon, Jean-Luc ;
Rother, Mark ;
Oliner, Kelly S. ;
Wolf, Michael ;
Gansert, Jennifer .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (31) :4697-4705
[4]   Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer:: The Gruppo Oncologico Nord Ovest [J].
Falcone, Alfredo ;
Ricci, Sergio ;
Brunetti, Isa ;
Pfanner, Elisabetta ;
Allegrini, Giacomo ;
Barbara, Cecilia ;
Crino, Lucio ;
Benedetti, Giovanni ;
Evangelista, Walter ;
Fanchini, Laura ;
Cortesi, Enrico ;
Picone, Vincenzo ;
Vitello, Stefano ;
Chiara, Silvana ;
Granetto, Cristina ;
Porcile, Gianfranco ;
Fioretto, Luisa ;
Orlandini, Cinzia ;
Andreuccetti, Michele ;
Masi, Gianluca .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) :1670-1676
[5]   The role of antiangiogenic agents in the treatment of patients with advanced colorectal cancer according to K-RAS status [J].
Garcia-Alfonso, Pilar ;
Grande, Enrique ;
Polo, Eduardo ;
Afonso, Ruth ;
Jose Reina, Juan ;
Jorge, Monica ;
Manuel Campos, Juan ;
Martinez, Virginia ;
Angeles, Cristina ;
Montagut, Clara .
ANGIOGENESIS, 2014, 17 (04) :805-821
[6]   Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200 [J].
Giantonio, Bruce J. ;
Catalano, Paul J. ;
Meropol, Neal J. ;
O'Dwyer, Peter J. ;
Mitchell, Edith P. ;
Alberts, Steven R. ;
Schwartz, Michael A. ;
Benson, Al B., III .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) :1539-1544
[7]   Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial [J].
Grothey, Axel ;
Van Cutsem, Eric ;
Sobrero, Alberto ;
Siena, Salvatore ;
Falcone, Alfredo ;
Ychou, Marc ;
Humblet, Yves ;
Bouche, Olivier ;
Mineur, Laurent ;
Barone, Carlo ;
Adenis, Antoine ;
Tabernero, Josep ;
Yoshino, Takayuki ;
Lenz, Heinz-Josef ;
Goldberg, Richard M. ;
Sargent, Daniel J. ;
Cihon, Frank ;
Cupit, Lisa ;
Wagner, Andrea ;
Laurent, Dirk .
LANCET, 2013, 381 (9863) :303-312
[8]   Extended RAS analysis for anti-epidermal growth factor therapy in patients with metastatic colorectal cancer [J].
Hecht, J. Randolph ;
Douillard, Jean-Yves ;
Schwartzberg, Lee ;
Grothey, Axel ;
Kopetz, Scott ;
Rong, Alan ;
Oliner, Kelly S. ;
Sidhu, Roger .
CANCER TREATMENT REVIEWS, 2015, 41 (08) :653-659
[9]   FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial [J].
Heinemann, Volker ;
von Weikersthal, Ludwig Fischer ;
Decker, Thomas ;
Kiani, Alexander ;
Vehling-Kaiser, Ursula ;
Al-Batran, Salah-Eddin ;
Heintges, Tobias ;
Lerchenmueller, Christian ;
Kahl, Christoph ;
Seipelt, Gernot ;
Kullmann, Frank ;
Stauch, Martina ;
Scheithauer, Werner ;
Hielscher, Joerg ;
Scholz, Michael ;
Mueller, Sebastian ;
Link, Hartmut ;
Niederle, Norbert ;
Rost, Andreas ;
Hoeffkes, Heinz-Gert ;
Moehler, Markus ;
Lindig, Reinhard U. ;
Modest, Dominik P. ;
Rossius, Lisa ;
Kirchner, Thomas ;
Jung, Andreas ;
Stintzing, Sebastian .
LANCET ONCOLOGY, 2014, 15 (10) :1065-1075
[10]   Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].
Hurwitz, H ;
Fehrenbacher, L ;
Novotny, W ;
Cartwright, T ;
Hainsworth, J ;
Heim, W ;
Berlin, J ;
Baron, A ;
Griffing, S ;
Holmgren, E ;
Ferrara, N ;
Fyfe, G ;
Rogers, B ;
Ross, R ;
Kabbinavar, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342
123